Following the direction of pharmaceutical purchasing reform, the price of consumables will be reduced by more than 50%

[trends of pharmaceutical network industry] high value medical consumables refer to those that directly affect human body, have strict requirements for safety, have large clinical use, relatively high price, and bear heavy expenses of the masses However, high value medical consumables have been criticized by all walks of life for their high price and excessive use But a few days ago came the good news: consumables management new deal is about to be implemented, part of the decline will be more than 50%! According to the requirements of the reform plan for the treatment of high value medical consumables, the premium for high value medical consumables should be cancelled by the end of this year, and medical institutions should be encouraged to jointly carry out negotiation and procurement with volume since the second half of 2019 At present, Anhui, Jiangsu and other provinces have begun to carry out pilot procurement of orthopedic materials, stents and other high-value medical consumables, and achieved phased results Among them, Jiangsu issued the implementation opinions on consumables sunshine procurement in July this year, and established a provincial Procurement Alliance At present, through a series of procedures such as negotiation, bidding, publicity, etc., 55 tertiary public hospitals started to purchase high-value medical consumables in volume on August 7, and 6 varieties of cardiac vascular stents and 25 varieties of dual chamber pacemakers became the first batch of procurement varieties It is reported that these two kinds of consumables are widely used in Jiangsu hospitals and account for a large proportion of medical expenses According to the agreement, within one year from October 1 this year, the first batch of selected manufacturers will obtain at least 70% of the purchase volume of 55 hospitals In addition, according to the plan, Jiangsu Province will realize online purchase of all medical consumables by the end of 2020, realize online price negotiation, online transaction and online supervision On July 16, Anhui Province, the implementation plan of negotiation and negotiation (pilot) for the centralized purchase of high-value medical consumables for public medical institutions affiliated to Anhui Province was officially released, which has more detailed and specific regulations on the purchase volume, purchase method, purchase scope and payment collection According to the plan, the high-value consumables with quantity procurement will be carried out in Anhui provincial public medical institutions as a pilot, gradually promoted to public medical institutions at and above the county level in the whole province, and other medical institutions will be encouraged to actively participate in the procurement In principle, the procurement cycle is one year Orthopedic implant (spine) and ophthalmic (intraocular lens) consumables are required to take part in the procurement of high-value medical consumables in Anhui Province, accounting for 70% and 90% of the procurement of high-value medical consumables in provincial public medical institutions in 2018 In addition, provincial public medical institutions are required to sign volume purchase and sales contracts with suppliers to ensure the purchase volume is completed within one year Or pilot on a larger scale Zhong Dongbo, director of the medical price and bidding procurement department of the State Medical Insurance Bureau, once disclosed in an interview that the main reform direction of high-value medical consumables procurement is basically the same as that of centralized drug volume procurement, i.e it is promoted by the principle of "integration of bidding and procurement, linking the volume and price", but considering the characteristics of high-value medical consumables and their use, in terms of the rules of selection, the subsequent use and other aspects, it also There should be different innovations It can be seen that, according to the plan of the state health insurance bureau, we will promote the procurement of high-value medical consumables in a larger scale nationwide on the basis of summing up the pilot experience of various regions The use of selected consumables is expected to achieve a win-win situation for both doctors and patients While the hospital can get more income, it also reduces the burden of medical insurance funds and solves the problem of "expensive medical treatment" for the common people According to the industry, when these high prices of drugs and consumables are squeezed out, the income structure of the hospital will be more reasonable, and the value of medical services can be further revealed.